vs
Custom Truck One Source, Inc.（CTOS）与West Pharmaceutical Services（WST）财务数据对比。点击上方公司名可切换其他公司
West Pharmaceutical Services的季度营收约是Custom Truck One Source, Inc.的1.9倍（$805.0M vs $422.2M），West Pharmaceutical Services净利率更高（16.4% vs -4.2%，领先20.6%），West Pharmaceutical Services同比增速更快（7.5% vs -8.5%），过去两年Custom Truck One Source, Inc.的营收复合增速更高（14.8% vs 7.6%）
Custom Truck One Source是北美领先的专用重型卡车及设备解决方案提供商，业务覆盖定制车辆制造、设备销售与租赁、售后配件供应及维保服务，主要服务基建、公用事业、建筑、能源等核心领域。
美国West Pharmaceutical Services是注射用药品包装及给药系统的设计和制造商，1923年成立，总部位于宾夕法尼亚州埃克斯顿。成立初期主营注射类药物包装用橡胶组件，曾为青霉素和胰岛素生产商提供符合无菌要求的配套产品。
CTOS vs WST — 直观对比
营收规模更大
WST
是对方的1.9倍
$422.2M
营收增速更快
WST
高出16.0%
-8.5%
净利率更高
WST
高出20.6%
-4.2%
两年增速更快
CTOS
近两年复合增速
7.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $422.2M | $805.0M |
| 净利润 | $-17.8M | $132.1M |
| 毛利率 | 20.3% | 37.8% |
| 营业利润率 | 2.9% | 19.5% |
| 净利率 | -4.2% | 16.4% |
| 营收同比 | -8.5% | 7.5% |
| 净利润同比 | -333.7% | 1.5% |
| 每股收益（稀释后） | $-0.08 | $1.82 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTOSWST
| Q1 26 | $422.2M | — | ||
| Q4 25 | $387.3M | $805.0M | ||
| Q3 25 | $359.9M | $804.6M | ||
| Q2 25 | $392.2M | $766.5M | ||
| Q1 25 | $307.1M | $698.0M | ||
| Q4 24 | $398.3M | $748.8M | ||
| Q3 24 | $337.5M | $746.9M | ||
| Q2 24 | $320.6M | $702.1M |
净利润CTOSWST
| Q1 26 | $-17.8M | — | ||
| Q4 25 | $20.9M | $132.1M | ||
| Q3 25 | $-5.8M | $140.0M | ||
| Q2 25 | $-28.4M | $131.8M | ||
| Q1 25 | $-17.8M | $89.8M | ||
| Q4 24 | $27.6M | $130.1M | ||
| Q3 24 | $-17.4M | $136.0M | ||
| Q2 24 | $-24.5M | $111.3M |
毛利率CTOSWST
| Q1 26 | 20.3% | — | ||
| Q4 25 | 31.8% | 37.8% | ||
| Q3 25 | 28.0% | 36.6% | ||
| Q2 25 | 26.1% | 35.7% | ||
| Q1 25 | 27.9% | 33.2% | ||
| Q4 24 | 29.7% | 36.5% | ||
| Q3 24 | 27.2% | 35.4% | ||
| Q2 24 | 27.8% | 32.8% |
营业利润率CTOSWST
| Q1 26 | 2.9% | — | ||
| Q4 25 | 13.4% | 19.5% | ||
| Q3 25 | 9.1% | 20.8% | ||
| Q2 25 | 7.1% | 20.1% | ||
| Q1 25 | 4.0% | 15.3% | ||
| Q4 24 | 16.9% | 21.3% | ||
| Q3 24 | 6.8% | 21.6% | ||
| Q2 24 | 5.5% | 18.0% |
净利率CTOSWST
| Q1 26 | -4.2% | — | ||
| Q4 25 | 5.4% | 16.4% | ||
| Q3 25 | -1.6% | 17.4% | ||
| Q2 25 | -7.2% | 17.2% | ||
| Q1 25 | -5.8% | 12.9% | ||
| Q4 24 | 6.9% | 17.4% | ||
| Q3 24 | -5.2% | 18.2% | ||
| Q2 24 | -7.6% | 15.9% |
每股收益（稀释后）CTOSWST
| Q1 26 | $-0.08 | — | ||
| Q4 25 | $0.10 | $1.82 | ||
| Q3 25 | $-0.03 | $1.92 | ||
| Q2 25 | $-0.13 | $1.82 | ||
| Q1 25 | $-0.08 | $1.23 | ||
| Q4 24 | $0.11 | $1.78 | ||
| Q3 24 | $-0.07 | $1.85 | ||
| Q2 24 | $-0.10 | $1.51 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $6.3M | $791.3M |
| 总债务越低越好 | $25.9M | $202.8M |
| 股东权益账面价值 | $809.1M | $3.2B |
| 总资产 | $3.4B | $4.3B |
| 负债/权益比越低杠杆越低 | 0.03× | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资CTOSWST
| Q1 26 | $6.3M | — | ||
| Q4 25 | $6.3M | $791.3M | ||
| Q3 25 | $13.1M | $628.5M | ||
| Q2 25 | $5.3M | $509.7M | ||
| Q1 25 | $5.4M | $404.2M | ||
| Q4 24 | $3.8M | $484.6M | ||
| Q3 24 | $8.4M | $490.9M | ||
| Q2 24 | $8.1M | $446.2M |
总债务CTOSWST
| Q1 26 | $25.9M | — | ||
| Q4 25 | $1.6B | $202.8M | ||
| Q3 25 | $1.6B | $202.7M | ||
| Q2 25 | $1.6B | $202.6M | ||
| Q1 25 | $1.6B | $202.6M | ||
| Q4 24 | $1.5B | $202.6M | ||
| Q3 24 | $1.6B | $202.6M | ||
| Q2 24 | $1.5B | $205.8M |
股东权益CTOSWST
| Q1 26 | $809.1M | — | ||
| Q4 25 | $809.1M | $3.2B | ||
| Q3 25 | $784.7M | $3.1B | ||
| Q2 25 | $790.1M | $2.9B | ||
| Q1 25 | $813.4M | $2.7B | ||
| Q4 24 | $861.3M | $2.7B | ||
| Q3 24 | $837.5M | $2.8B | ||
| Q2 24 | $856.7M | $2.6B |
总资产CTOSWST
| Q1 26 | $3.4B | — | ||
| Q4 25 | $3.4B | $4.3B | ||
| Q3 25 | $3.5B | $4.1B | ||
| Q2 25 | $3.6B | $4.0B | ||
| Q1 25 | $3.5B | $3.6B | ||
| Q4 24 | $3.5B | $3.6B | ||
| Q3 24 | $3.6B | $3.7B | ||
| Q2 24 | $3.5B | $3.5B |
负债/权益比CTOSWST
| Q1 26 | 0.03× | — | ||
| Q4 25 | 2.03× | 0.06× | ||
| Q3 25 | 2.10× | 0.07× | ||
| Q2 25 | 2.04× | 0.07× | ||
| Q1 25 | 1.97× | 0.08× | ||
| Q4 24 | 1.77× | 0.08× | ||
| Q3 24 | 1.87× | 0.07× | ||
| Q2 24 | 1.79× | 0.08× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $251.1M |
| 自由现金流经营现金流 - 资本支出 | — | $175.0M |
| 自由现金流率自由现金流/营收 | — | 21.7% |
| 资本支出强度资本支出/营收 | — | 9.5% |
| 现金转化率经营现金流/净利润 | — | 1.90× |
| 过去12个月自由现金流最近4个季度 | — | $468.9M |
8季度趋势，按日历期对齐
经营现金流CTOSWST
| Q1 26 | — | — | ||
| Q4 25 | $47.3M | $251.1M | ||
| Q3 25 | $81.5M | $197.2M | ||
| Q2 25 | $125.7M | $177.1M | ||
| Q1 25 | $55.6M | $129.4M | ||
| Q4 24 | $82.1M | $190.1M | ||
| Q3 24 | $16.5M | $180.1M | ||
| Q2 24 | $37.8M | $165.0M |
自由现金流CTOSWST
| Q1 26 | — | — | ||
| Q4 25 | — | $175.0M | ||
| Q3 25 | — | $133.9M | ||
| Q2 25 | — | $101.9M | ||
| Q1 25 | — | $58.1M | ||
| Q4 24 | — | $85.2M | ||
| Q3 24 | — | $98.8M | ||
| Q2 24 | — | $64.8M |
自由现金流率CTOSWST
| Q1 26 | — | — | ||
| Q4 25 | — | 21.7% | ||
| Q3 25 | — | 16.6% | ||
| Q2 25 | — | 13.3% | ||
| Q1 25 | — | 8.3% | ||
| Q4 24 | — | 11.4% | ||
| Q3 24 | — | 13.2% | ||
| Q2 24 | — | 9.2% |
资本支出强度CTOSWST
| Q1 26 | — | — | ||
| Q4 25 | — | 9.5% | ||
| Q3 25 | — | 7.9% | ||
| Q2 25 | — | 9.8% | ||
| Q1 25 | — | 10.2% | ||
| Q4 24 | — | 14.0% | ||
| Q3 24 | — | 10.9% | ||
| Q2 24 | — | 14.3% |
现金转化率CTOSWST
| Q1 26 | — | — | ||
| Q4 25 | 2.27× | 1.90× | ||
| Q3 25 | — | 1.41× | ||
| Q2 25 | — | 1.34× | ||
| Q1 25 | — | 1.44× | ||
| Q4 24 | 2.98× | 1.46× | ||
| Q3 24 | — | 1.32× | ||
| Q2 24 | — | 1.48× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTOS
| Equipment sales | $273.9M | 65% |
| Rental revenue | $116.3M | 28% |
| Parts sales and services | $32.1M | 8% |
WST
| Proprietary Products | $661.8M | 82% |
| Contract Manufactured Products | $143.2M | 18% |
| Affiliated Entity | $3.3M | 0% |
